An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr-Reference-Cited by-同舟云学术

An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr

Published:2000-05 Issue:10 Volume:25 Page:1109-1110
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Polák J,Koza V,Cetkovský P,Haškovec C

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1702412.pdf

Reference10 articles.

1. Melo JV . The diversity of BCR/ABL fusion proteins and their relationship to leukemia phenotype Blood 1996 88: 2375–2384

2. Saglio G, Guerrasio A, Rosso C et al. New type of Bcr/Abl junction in Philadelphia chromosome-positive chronic myelogenous leukemia Blood 1990 76: 1819–1824

3. Pane F, Frigeri F, Sindona M et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). (Erratum Blood 1997; 89: 4244 ) Blood 1996 88: 2410–2414

4. Yamagata T, Mitani K, Kanda Y et al. Elevated platelet count features the variant type of BCR/ABL junction in chronic myelogenous leukemia Br J Haematol 1996 94: 370–372

5. Mittre H, Leymarie P, Macro M, Leporrie M . A new case of chronic myeloid leukemia with c3/a2 BCR/ABL junction Is it really a distinct disease? Blood 1997 89: 4239–4240

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Philadelphia chromosome-positive acute lymphoblastic leukemia carrying the p230 μ-<i>BCR-ABL1</i> fusion gene;Tenri Medical Bulletin;2022-12-25

2. Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation;Cancer Genetics and Cytogenetics;2010-05

3. L’oncoprotéine Bcr-Abl de 230 kDa induit-elle un syndrome distinct de la leucémie myéloïde chronique ?;Hématologie;2009-11

4. A Case of Atypical CML with Micro BCR/ABL Rearrangement;The Korean Journal of Hematology;2008

5. First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR–ABL transcripts;Hematological Oncology;2007